Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of skin infections
3.2.1.2 Rising antibiotic resistance
3.2.1.3 Expanding advancements in formulations
3.2.1.4 Growing regulatory support
3.2.2 Industry pitfalls & challenges
3.2.2.1 Adverse effects and safety concerns
3.2.2.2 Preference for systemic antibiotics
3.3 Growth potential analysis
3.4 Pipeline analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Drug Class, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Tetracycline
5.3 Aminoglycoside
5.4 Erythromycin
5.5 Clindamycin
5.6 Other drug classes
Chapter 6 Market Estimates and Forecast, By Dosage Form, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Ointments
6.3 Creams
6.4 Solutions
6.5 Powders
6.6 Other dosage forms
Chapter 7 Market Estimates and Forecast, By Product Type, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Branded
7.3 Generics
Chapter 8 Market Estimates and Forecast, By Medication Type, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Over-the-counter (OTC)
8.3 Prescription
Chapter 9 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 Skin infection
9.3 Eye infection
9.4 Ear infection
9.5 Nasal infections
9.6 Other applications
Chapter 10 Market Estimates and Forecast, By Distribution Channel, 2018 – 2032 ($ Mn)
10.1 Key trends
10.2 Hospital pharmacies
10.3 Retail pharmacies & drug stores
10.4 Online pharmacies
Chapter 11 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
11.1 Key trends, by region
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Spain
11.3.5 Italy
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 Rest of Asia Pacific
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America
11.6 Middle East and Africa
11.6.1 South Africa
11.6.2 Saudi Arabia
11.6.3 Rest of Middle East and Africa
Chapter 12 Company Profiles
12.1 Almirall S.A.
12.2 Bausch Health Companies Inc.
12.3 Bayer AG
12.4 GlaxoSmithKline plc
12.5 Johnson & Johnson Consumer Inc.
12.6 Lupin
12.7 Medimetriks Pharmaceuticals Inc.
12.8 Merck & Co., Inc.
12.9 Mayne Pharma Group Limited.
12.10 Novartis AG
12.11 Pfizer Inc.
12.12 Sanofi
12.13 Sun Pharmaceutical Industries Ltd.
12.14 Teva Pharmaceutical Industries Ltd.
12.15 Viatris Inc.
